Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 0 | 0 | 0 | 0 |
Cost of revenue | — | — | — | — |
Gross profit | — | — | — | — |
Operating expense | ||||
Research & development | 4.2M | 3.4M | 3.4M | 3.6M |
Selling general and admin | 3.3M | 3.7M | 3.0M | 3.6M |
Other operating expenses | — | — | — | — |
Operating income | -7.4M | -7.2M | -6.4M | -7.1M |
Non operating interest income | ||||
Income | 720K | 837K | 1.0M | 1.1M |
Expense | — | — | — | — |
Other income expense | -24K | -33K | -1.8M | -17K |
Pretax income | -6.7M | -6.3M | -7.2M | -6.0M |
Tax provision | 0 | 0 | 0 | 0 |
Net income | -6.7M | -6.3M | -7.2M | -6.0M |
Basic EPS | -0.1 | — | -0.1 | -0.1 |
Diluted EPS | -0.1 | — | -0.1 | -0.1 |
Basic average shares | 129.2M | — | 125.8M | 125.7M |
Diluted average shares | 129.2M | — | 125.8M | 125.7M |
EBITDA | -7.4M | -7.1M | -4.7M | -7.1M |
Net income from continuing op. | -6.7M | -6.3M | -7.2M | -6.0M |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |